Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma.
Varsha JainSriram VenigallaRonnie A SebroGiorgos C KarakousisRobert J WilsonKristy L WeberJacob E ShabasonPublished in: Cancer medicine (2019)
In a large modern cohort identified from the NCDB, commercial insurance status in patients <65 years was associated early diagnosis, receipt of neoadjuvant/adjuvant radiation therapy, and overall survival for patients with soft tissue sarcoma. Further efforts are warranted to understand disparities in care based on health insurance in the United States.
Keyphrases
- health insurance
- affordable care act
- radiation therapy
- end stage renal disease
- newly diagnosed
- ejection fraction
- healthcare
- locally advanced
- early stage
- quality improvement
- prognostic factors
- palliative care
- rectal cancer
- squamous cell carcinoma
- type diabetes
- patient reported outcomes
- pain management
- case report
- combination therapy
- weight loss
- chronic pain
- replacement therapy
- free survival